Picton Mahoney Asset Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-389,418
Closed -$2.7M 878
2024
Q3
$2.7M Sell
389,418
-217,672
-36% -$1.71M 0.09% 196
2024
Q2
$4.74M Buy
607,090
+118,703
+24% +$879K 0.18% 160
2024
Q1
$3.47M Buy
+488,387
New +$3.23M 0.1% 173

Other funds holding GDRX

Picton Mahoney Asset Management's GDRX Position: Q4 2024 in Review

Picton Mahoney Asset Management sold out of GoodRx Holdings (GDRX) in Q4 2024, closing a stake of 389,418 shares — an estimated $2.7M sold.

Picton Mahoney Asset Management first reported a position in GDRX in Q1 2024 and held it in 3 quarters. The position peaked at $4.74M in Q2 2024. 170 funds tracked by Wall St. Rank hold GDRX as of Q4 2024.

  • Picton Mahoney Asset Management reported no remaining GoodRx Holdings position as of Q4 2024 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 389,418 GoodRx Holdings shares in Q4 2024, an estimated $2.7M.
  • Picton Mahoney Asset Management first reported a position in GoodRx Holdings in Q1 2024 and held it in 3 quarters.
  • Picton Mahoney Asset Management's GoodRx Holdings position peaked at $4.74M in Q2 2024.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2024.

Based on Picton Mahoney Asset Management's 13F filing for Q4 2024, filed 10 Feb 2025.